GNLX
Genelux Corporation
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Thomas D. Zindrick
IPO Date
2023-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Genelux Corporation
CEO
Thomas D. Zindrick
IPO Date
2023-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 233,957 |
| $0.00 |
| 18 Jun 2026 | Cappello Joseph | Chief Technical Officer | A-Award | Acquired | 174,841 | $0.00 |
| 18 Jun 2026 | Tyree James L | director | A-Award | Acquired | 28,409 | $0.00 |
| 18 Jun 2026 | Tyree James L | director | A-Award | Acquired | 31,566 | $3.03 |
| 18 Jun 2026 | Zindrick Thomas | President and CEO | A-Award | Acquired | 730,601 | $0.00 |
| 18 Jun 2026 | Thomas John | director | A-Award | Acquired | 28,409 | $0.00 |
| 18 Jun 2026 | Thomas John | director | A-Award | Acquired | 31,566 | $3.03 |
| 18 Jun 2026 | Mirabelli Mary | director | A-Award | Acquired | 28,409 | $0.00 |
| 18 Jun 2026 | Mirabelli Mary | director | A-Award | Acquired | 31,566 | $3.03 |